Pembrolizumab frontline monotherapy in patients with NSCLC and high PD-L1 expression: Real-world data from a European Cohort with focus on subgroups of interest von Mountzios, G., Signorelli, D., Cobo, J Rey, Banini, M., Economopoulou, P., Russo, G Lo, Baxevanos, P.T., Roila, F., de Toma, A., Banna, G., Christopoulou, A., Jimenez, B., Linardou, H., Calles, A., Galetta, D., Addeo, A., Camerini, A., Kosmidis, P.A., Garassino, M.C., Metro, G.

Volltext

1518P - Pembrolizumab frontline monotherapy in patients with NSCLC and high PD-L1 expression: Real-world data from a European Cohort with focus on subgroups of interest von Mountzios, G., Signorelli, D., Cobo, J Rey, Banini, M., Economopoulou, P., Russo, G Lo, Baxevanos, P.T., Roila, F., de Toma, A., Banna, G., Christopoulou, A., Jimenez, B., Linardou, H., Calles, A., Galetta, D., Addeo, A., Camerini, A., Kosmidis, P.A., Garassino, M.C., Metro, G.

Volltext

142TiP SARC-Digital: An obServational, rAndomized, pRospeCtive study of the impact of digital health interventions on symptom and side-effect management in patients with metastatic... von Kokkali-Zervos, S., Moreno, J. Durán, Kyriazoglou, A., Georgoulias, V., Athanasiadis, I., Koumarianou, A., Tsoukalas, N.G., Ramfidis, V., Stergioula, A., Kosmidis, P.A., Valoukas, D.A., Tzanninis, D., Varvaris, G., Baxevanos, P.T., Kosmidis, T., Schoina, V., Boukovinas, I.

Volltext